drugset / Trial / NCT00226109

Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics

NCT00226109

Phase 4 Suspended 40 enrolled University of Aarhus
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Chronic alcoholics suffer from weak skeletal and cardiac muscle. The investigators have discovered a beneficial effect of spironolactone-treatment in that regard. Therefore, a double blind placebo controlled study is conducted, to examine the effects of spironolactone on cardiac and skeletal muscle-function in chronic alcoholics.

Timeline

Start
2004-04
Primary completion
2011-08
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Spironolactone Small molecule 100 mg